| # | Drug | Count |
|---|---|---|
| 0 | ERGOCALCIFEROL | 5 |
| 1 | ADALIMUMAB | 4 |
| 2 | OLANZAPINE | 3 |
| 3 | ACETAMINOPHEN | 2 |
| 4 | CALCIUM | 2 |
| 5 | CANAGLIFLOZIN | 2 |
| 6 | CITALOPRAM | 2 |
| 7 | CITALOPRAM HYDROBROMIDE | 2 |
| 8 | DIPHENHYDRAMINE HYDROCHLORIDE | 2 |
| 9 | DOXYCYCLINE | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SODIUM MONOFLUOROPHOSPHATE | 1 | 0.0027 |
| 1 | CETYLPYRIDINIUM CHLORIDE | 1 | 0.0015 |
| 2 | PSYLLIUM HUSK | 1 | 0.0007 |
| 3 | BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE CAPSULES | 1 | 0.0006 |
| 4 | SODIUM FLUORIDE | 1 | 0.0003 |
| 5 | NALOXEGOL OXALATE | 1 | 0.0003 |
| 6 | OLOPATADINE HYDROCHLORIDE OPHTHALMIC | 1 | 0.0002 |
| 7 | PROPAFENONE | 1 | 0.0002 |
| 8 | CYPROHEPTADINE HYDROCHLORIDE | 1 | 0.0002 |
| 9 | OLOPATADINE HYDROCHLORIDE | 1 | 0.0002 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 4 |
| 1 | Benzodiazepine [EPC] | 2 |
| 2 | Calcium [EPC] | 2 |
| 3 | GLP-1 Receptor Agonist [EPC] | 2 |
| 4 | Insulin Analog [EPC] | 2 |
| 5 | Opioid Agonist [EPC] | 2 |
| 6 | Serotonin Reuptake Inhibitor [EPC] | 2 |
| 7 | Tetracycline-class Drug [EPC] | 2 |
| 8 | Allylamine Antifungal [EPC] | 1 |
| 9 | Androgen [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Calcitonin Gene-related Peptide Receptor Antagonist [EPC] | 1 | 0.0001 |
| 1 | Allylamine Antifungal [EPC] | 1 | 0.0001 |
| 2 | Barbiturate [EPC] | 1 | 0.0001 |
| 3 | Non-narcotic Antitussive [EPC] | 1 | 0.0001 |
| 4 | Human Immunoglobulin G [EPC] | 1 | 0.0000 |
| 5 | Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] | 1 | 0.0000 |
| 6 | Androgen [EPC] | 1 | 0.0000 |
| 7 | Tetracycline-class Drug [EPC] | 2 | 0.0000 |
| 8 | Serotonin Reuptake Inhibitor [EPC] | 2 | 0.0000 |
| 9 | Muscle Relaxant [EPC] | 1 | 0.0000 |